XML 47 R40.htm IDEA: XBRL DOCUMENT v3.25.1
Revenue Recognition - Additional Information (Detail) - USD ($)
$ in Thousands
 3 Months Ended
Nov. 30, 2023
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Disaggregation of Revenue [Line Items]        
Revenue from contract with customers excluding assessed tax   $ 255,737 $ 145,820  
Contract with customer liability amount of revenue recognized that was included in the opening balance   26,900 11,100  
Accounts Receivable [Member]        
Disaggregation of Revenue [Line Items]        
Contract with customer receivable after allowance for credit loss current   5,200   $ 4,100
Long-Term Contract with Customer [Member]        
Disaggregation of Revenue [Line Items]        
Revenue, remaining performance obligation   194,300    
Commercialization and Reference Laboratory Agreement Member With Personalis Inc [Member]        
Disaggregation of Revenue [Line Items]        
Term of agreement 3 years      
Personalis Inc [Member] | Commercialization and Reference Laboratory Agreement Member With Personalis Inc [Member]        
Disaggregation of Revenue [Line Items]        
Aggregate milestone amount payable $ 12,000      
Cumulative amount paid   10,000    
Contract with customer assets net current   $ 3,800   $ 3,000
Personalis Inc [Member] | Commercialization and Reference Laboratory Agreement [Member]        
Disaggregation of Revenue [Line Items]        
Class Of Warrant Share Issued   9,218,800    
One Year [Member] | Long-Term Contract with Customer [Member]        
Disaggregation of Revenue [Line Items]        
Revenue, remaining performance obligation, percentage   59.00%    
Two Year [Member] | Long-Term Contract with Customer [Member]        
Disaggregation of Revenue [Line Items]        
Revenue, remaining performance obligation, percentage   29.00%    
Three Year [Member] | Long-Term Contract with Customer [Member]        
Disaggregation of Revenue [Line Items]        
Revenue, remaining performance obligation, percentage   12.00%    
Genomics Product [Member]        
Disaggregation of Revenue [Line Items]        
Revenue from contract with customers excluding assessed tax   $ 193,800 102,600  
Genomics Product [Member] | Self-Pay [Member]        
Disaggregation of Revenue [Line Items]        
Revenue from contract with customers excluding assessed tax   12,300 9,200  
Clinical Order [Member] | Third-Party Payor [Member]        
Disaggregation of Revenue [Line Items]        
Revenue from contract with customers excluding assessed tax   181,500 93,400  
Insights Product [Member]        
Disaggregation of Revenue [Line Items]        
Revenue from contract with customers excluding assessed tax   49,500 31,300  
Trials Product [Member]        
Disaggregation of Revenue [Line Items]        
Revenue from contract with customers excluding assessed tax   9,700 11,300  
Data And Other [Member]        
Disaggregation of Revenue [Line Items]        
Revenue from contract with customers excluding assessed tax   $ 61,900 $ 43,300